Kyverna Therapeutics Inc
KYTX3.370USD
-0.070-2.03%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
3.370USD+3.370After-hours (ET)
145.65MMarket Cap
LossP/E TTM
Kyverna Therapeutics Inc
3.370
-0.070-2.03%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
Total equity
Cash, cash equivalents and short-term investments
-34.38%242.65M
396.98%285.98M
316.16%321.59M
--346.24M
--369.79M
--57.54M
--77.27M
- Cash and cash equivalents
-74.65%56.87M
178.87%96.62M
355.71%104.66M
--131.62M
--224.29M
--34.65M
--22.97M
-Short-term investments
27.68%185.78M
727.04%189.36M
299.44%216.92M
--214.62M
--145.51M
--22.90M
--54.31M
Prepaid expenses
-12.15%5.00M
48.09%4.62M
77.29%3.79M
--2.59M
--5.69M
--3.12M
--2.14M
Other current assets
--0.00
----
----
----
----
----
----
Total current assets
-34.05%247.65M
379.03%290.60M
309.74%325.37M
--348.82M
--375.49M
--60.66M
--79.41M
Non-current assets
Net Fixed Assets
-30.97%8.80M
0.43%10.66M
2.81%11.38M
--12.51M
--12.75M
--10.61M
--11.07M
-Fixed Assets
-17.74%12.74M
9.39%14.33M
10.52%14.73M
--15.53M
--15.48M
--13.10M
--13.33M
-Accumulated depreciation
44.00%3.93M
47.59%3.67M
48.38%3.35M
--3.02M
--2.73M
--2.49M
--2.25M
Other non-current assets
140.88%4.20M
-13.59%3.39M
21.70%2.44M
--1.79M
--1.74M
--3.92M
--2.00M
Total non-current assets
-10.29%13.00M
-3.35%14.04M
5.71%13.82M
--14.29M
--14.50M
--14.53M
--13.08M
Total assets
-33.16%260.65M
305.14%304.64M
266.75%339.20M
--363.12M
--389.98M
--75.19M
--92.49M
Liabilities
Current liabilities
-Other payables
286.18%11.91M
299.52%14.06M
117.96%6.43M
--5.78M
--3.08M
--3.52M
--2.95M
Accrued expenses
22.54%9.33M
22.85%11.13M
31.89%10.69M
--8.97M
--7.61M
--9.06M
--8.11M
Short-term debt and lease liabilities
-48.21%507.00K
-18.51%779.00K
3.79%931.00K
--1.00M
--979.00K
--956.00K
--897.00K
-Short-term lease liabilities
-48.21%507.00K
-18.51%779.00K
3.79%931.00K
--1.00M
--979.00K
--956.00K
--897.00K
Other current liabilities
286.18%11.91M
299.52%14.06M
117.96%6.43M
--5.78M
--3.08M
--3.52M
--2.95M
Total current liabilities
52.26%33.29M
69.98%33.76M
83.63%30.98M
--23.48M
--21.86M
--19.86M
--16.87M
Non-current liabilities
Long-term debt and lease liabilities
-49.23%3.28M
-20.58%4.16M
-13.84%4.97M
--5.72M
--6.46M
--5.24M
--5.77M
-Long-term lease liabilities
-49.23%3.28M
-20.58%4.16M
-13.84%4.97M
--5.72M
--6.46M
--5.24M
--5.77M
Other non-current liabilities
--0.00
----
--296.00K
----
----
--0.00
--0.00
Total non-current liabilities
-52.96%3.35M
-30.15%4.30M
-19.62%5.50M
--6.13M
--7.13M
--6.16M
--6.84M
Total liabilities
26.39%36.65M
46.28%38.06M
53.83%36.49M
--29.61M
--28.99M
--26.02M
--23.72M
Shareholders' equity
Common equity
1.61%532.17M
11316.48%530.00M
14725.47%528.59M
--525.09M
--523.73M
--4.64M
--3.57M
Preferred equity
----
----
----
----
----
--180.57M
--180.57M
Retained earnings
-89.36%-308.15M
-93.70%-263.52M
-95.91%-226.03M
---191.54M
---162.74M
---136.04M
---115.38M
Capital reserves
1.61%532.17M
11317.54%530.00M
14727.15%528.59M
--525.09M
--523.73M
--4.64M
--3.56M
Gains losses not affecting retained earnings
0.00%-1.00K
2525.00%105.00K
2960.00%153.00K
---37.00K
---1.00K
--4.00K
--5.00K
Total equity
-37.95%224.01M
442.10%266.59M
340.19%302.71M
--333.51M
--360.99M
--49.18M
--68.77M
Currency unit
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
